证券之星消息，1月7日南向资金减持367.45万股锦欣生殖（01951.HK）。近5个交易日中，获南向资金 减持的有4天，累计净减持701.7万股。近20个交易日中，获南向资金减持的有14天，累计净减持2917.7 万股。截至目前，南向资金持有锦欣生殖（01951.HK）14.56亿股，占公司已发行普通股的52.78%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 锦欣生殖医疗集团有限公司是一家投资控股公司，主要提供试管受精（IVF）服务。该公司通过其子公 司主要提供辅助生殖服务、管理服务、流动手术中心设施服务、辅助医疗服务、妇产儿科医疗服务，以 及从事医疗消耗品及设备销售业务。该公司主要在中国及美国提供服务。 ...

证券代码：601567 证券简称：三星医疗 公告编号：临2026-001 宁波三星医疗电气股份有限公司 法定代表人：沈国英 注册资本：1,405,209,400元 成立日期：2007年02月01日 关于完成工商变更登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 宁波三星医疗电气股份有限公司（以下简称"公司"）于2025年10月29日召开第六届董事会第二十六次会 议，审议通过了《关于公司变更注册资本、修订〈公司章程〉并办理工商变更登记的议案》。具体详见 公司于2025年10月30日披露于上海证券交易所网站（www.sse.com.cn）、中国证券报、上海证券报和证 券时报的《三星医疗第六届董事会第二十六次会议决议公告》（公告编号：临2025-082）、《三星医疗 关于公司变更注册资本、修订〈公司章程〉并办理工商变更登记的公告》（公告编号：临2025-083）等 相关公告。 近日，公司完成了相关工商变更登记手续，并取得了宁波市市场监督管理局换发的《营业执照》。工商 登记变更后，相关登记信息如下： 公司名称：宁波三星医疗 ...

陆玲特别提醒，有诊疗需求的市民，可在下午5点后，到中大医院本部急诊科，挂急诊耳鼻咽喉头颈外 科号，进行相关检查后，专科医生给出相关建议与诊疗方案。 通讯员 刘敏 南京晨报/爱南京记者 钱鸣 晚间也能在喉镜下取鱼刺，接受鼻内镜、耳内镜及听功能检查吗？答案是可以的。从1月5日起，东南大 学附属中大医院耳鼻咽喉头颈外科正式推出晚间专科检查诊疗服务，将周一至周日的诊疗时间延伸至晚 上10点，为上班族、学生群体、白天不便就诊以及鱼刺卡喉、突发耳聋等耳鼻咽喉头颈外科患者，提供 便捷的"错峰就医"新方案。 中大医院耳鼻咽喉头颈外科主任陆玲教授介绍，中大医院新增的耳鼻咽喉头颈外科专科诊疗服务，从下 午5点到晚上10点，可为市民提供电子喉镜、鼻内镜、耳内镜及听功能检查等检查项目。 作为耳鼻咽喉疾病诊断的"精准利器"，各类内镜检查在晚间门诊实现"全流程专业落地"：电子喉镜凭借 高清成像技术，可精准捕捉声带小结、咽喉黏膜病变等细微问题，为咽炎、喉炎、声带息肉等疾病提供 可靠诊断依据，同时针对晚间高发的鱼刺卡喉等情况，能即时开展异物取出操作，解决患者晚间鱼刺等 异物找不到、取不出的难题；鼻内镜深入鼻腔内部，可明确鼻出血病因、定位出血 ...

Group 1: Economic Development and Employment - Xiaomi Group's comprehensive management department has created over 5000 direct jobs and produced more than 500,000 vehicles since its factory's inception, contributing to local employment and economic growth [1] - The establishment of a collaborative automotive industry ecosystem in the Beijing-Tianjin-Hebei region has been facilitated by Xiaomi's initiatives, which include attracting supporting enterprises like CATL [1] Group 2: Healthcare Initiatives - The establishment of eight tertiary medical institutions in the urban sub-center has significantly advanced healthcare, although challenges in resource integration for cardiovascular disease prevention remain [2] - A proposed "131" strategic framework aims to enhance the sharing of cardiovascular health resources across community health service centers and secondary hospitals, ensuring comprehensive access to quality healthcare [2] Group 3: Technology and Cultural Integration - The "Mars Science Fiction City" project aims to integrate advanced technology into everyday life, utilizing resources from Tsinghua University and the Chinese Academy of Sciences to create immersive educational experiences [3] - The project emphasizes the importance of making science popular and engaging, serving as a model for the integration of technology and culture in the urban sub-center [3] Group 4: Agricultural Modernization - The modernization of agriculture is highlighted as a key focus, emphasizing the integration of information technology and biotechnology to enhance productivity and economic viability in rural areas [3]

（编辑 袁冠琳） 证券日报网讯 1月7日，国际医学在互动平台回答投资者提问时表示，公司财务状况稳健，经营性现金 流持续为正，资信状况良好，不存在债务风险。公司控股股东及一致行动人资信状况良好，具备较强的 资金偿还能力，质押风险可控。本次非公开发行是为了顺应国家政策，把握"银发经济"发展机遇。优化 资本结构，盘活存量资产，为未来业绩增长奠定坚实基础。 ...

（文章来源：证券日报） 证券日报网讯 1月7日，奥精医疗发布公告称，公司2025年度财务审计机构立信会计师事务所内部调 整，签字注册会计师由常明、周末变更为田伟、周末，继续完成本年度审计工作。 ...

Core Insights - A strategic collaboration has been established between Jiangsu Su Bei People's Hospital and Soochow University, marking a significant step in optimizing the regional healthcare development landscape [1] - The partnership aims for deep integration and strategic synergy, focusing on talent cultivation, discipline construction, and research transformation [4][5] Group 1: Collaboration Objectives - The collaboration is designed to create a systematic and strategic integration of resources, enhancing the hospital's high-quality development through talent and innovation [4] - The partnership will leverage Soochow University's strengths in basic research and talent training, combined with the clinical resources of Su Bei People's Hospital, to create a system effect greater than the sum of its parts [5] Group 2: Impact on Su Bei People's Hospital - The collaboration will accelerate discipline construction in critical health areas such as hematology, orthopedics, and cardiovascular surgery, supported by top-tier teams from Soochow University [6] - The deep collaboration will break down barriers between basic research and clinical practice, allowing for more efficient translation of research outcomes into clinical applications [6] - The partnership will enhance the hospital's capacity for independent talent cultivation, providing systematic support for medical graduate training and the development of high-level local talent [6] Group 3: Benefits for "Healthy Yangzhou" - The establishment of collaborative innovation centers will facilitate the introduction of top medical technologies and management experiences to Yangzhou, improving local treatment capabilities for complex diseases [7] - The collaboration aims to attract and cultivate high-end medical talent in Yangzhou, producing locally relevant disease prevention and treatment outcomes [7] - The partnership is expected to provide clinical validation and project sources for the biomedicine and health industry in Yangzhou and Jiangsu, promoting a virtuous cycle among medicine, industry, academia, and research [7] Group 4: Future Prospects - The collaboration symbolizes a commitment to responsibility and local development, with expectations for significant advancements in academic co-construction, talent cultivation, and resource sharing [8] - The partnership is anticipated to serve as a model for university-hospital integration, enhancing the comprehensive strength of Su Bei People's Hospital and supporting the construction of "Healthy Yangzhou" [8]

Core Viewpoint - The establishment of a four-level telemedicine system by the Xinjiang Production and Construction Corps (XPCC) enables 90% of patients to receive medical consultations within their local area, addressing the challenges of accessibility and convenience in healthcare services [1][3]. Group 1: Telemedicine Implementation - The XPCC has developed a comprehensive telemedicine system that allows for rapid diagnosis and treatment, exemplified by a case where a patient received a heart attack diagnosis and treatment plan within 10 minutes through remote consultation [1]. - The telemedicine system provides essential imaging services such as X-rays, ultrasounds, and CT scans, allowing patients to receive authoritative diagnoses from top-tier hospitals without traveling long distances [1]. Group 2: Data Integration and Resource Allocation - The XPCC is advancing the construction of a national health data center, integrating data from various healthcare institutions, which has led to the initial realization of data aggregation across all medical facilities [2]. - A focus on a tiered diagnosis and treatment system is being implemented, utilizing 17 tightly-knit medical communities to ensure the rational allocation of quality healthcare resources and orderly patient flow [2]. Group 3: Enhancing Healthcare Services - The XPCC is expanding "Internet + Healthcare" applications, with various medical institutions offering online services such as family doctor contracts and nursing care, particularly benefiting patients with mobility issues [2]. - The integration of 5G technology in remote collaborative services is being piloted, facilitating real-time responses for chronic disease management and medication guidance [2]. Group 4: Training and Professional Development - The XPCC is leveraging its telemedicine system for talent cultivation, providing systematic learning platforms for healthcare professionals, including training in remote teaching and surgical guidance [3]. - A tiered diagnosis model has been established, with a stable in-region consultation rate of around 90%, while the rate of patient transfers to higher-level hospitals is decreasing [3].

在深圳和睦家医院，新风天域集团大湾区首席运营官萧毅晃接受记者采访（2025年11月27日摄）。新华社发（龙镜伊摄） 新华社香港1月7日电 题：双向奔赴 "医"路同行——粤港澳大湾区医疗协同发展迈入新阶段 郭辛 "过去查出大病，第一反应就是回香港用进口药。现在我会根据治疗方案，灵活选择在香港或内地就医，真正感受到大湾区医疗资源互补带来的便 利。"在深圳和睦家医院完成阶段性化疗后返港复查的香港市民郭嘉麟，谈起跨境就医的经历，语气中透着从容与笃定。 眼下，假日"北上"已成为香港市民的生活常态。除了购物、餐饮、娱乐等传统消费，越来越多港人将深圳、广州等粤港澳大湾区内地城市作为"北 上就医"的新选择。医疗资源共享、服务体系衔接、生活圈互联互通，正悄然重塑大湾区居民的生活轨迹。 多"一条路"：选择更多元 信心更充足 2020年，在上海工作的郭嘉麟被诊断为肺癌晚期。当时，因对内地重大疾病治疗水平了解不深，确诊仅一周，他便选择返港接受靶向治疗。 几年后，当病情需要调整治疗方案时，已在香港一家非营利癌症关怀机构担任义工的郭嘉麟从志愿者朋友处了解到，深圳的医疗机构能提供更灵 活、个性化的化疗服务。于是，他开启了每周一次北上治疗的 ...

证券之星消息，截至2026年1月7日收盘，通策医疗(600763)报收于41.02元，下跌0.65%，换手率 1.34%，成交量5.99万手，成交额2.46亿元。 1月7日的资金流向数据方面，主力资金净流出2848.85万元，占总成交额11.56%，游资资金净流入 914.14万元，占总成交额3.71%，散户资金净流入1934.71万元，占总成交额7.85%。 近5日资金流向一览见下表： 该股主要指标及行业内排名如下： 通策医疗2025年三季报显示，前三季度公司主营收入22.9亿元，同比上升2.56%；归母净利润5.14亿 元，同比上升3.16%；扣非净利润5.09亿元，同比上升3.09%；其中2025年第三季度，公司单季度主营收 入8.42亿元，同比上升2.34%；单季度归母净利润1.92亿元，同比上升2.31%；单季度扣非净利润1.92亿 元，同比上升1.85%；负债率25.1%，投资收益4122.43万元，财务费用3192.82万元，毛利率41.69%。通 策医疗（600763）主营业务：医疗服务。 该股最近90天内共有7家机构给出评级，买入评级4家，增持评级3家；过去90天内机构目标均价为 52.88 ...